CRISPR/Cas9 application in cancer therapy: a pioneering genome editing tool
S Shojaei Baghini, ZR Gardanova, SAH Abadi… - Cellular & Molecular …, 2022 - Springer
The progress of genetic engineering in the 1970s brought about a paradigm shift in genome
editing technology. The clustered regularly interspaced short palindromic repeats/CRISPR …
editing technology. The clustered regularly interspaced short palindromic repeats/CRISPR …
Efficient gene knockout and genetic interaction screening using the in4mer CRISPR/Cas12a multiplex knockout platform
N Esmaeili Anvar, C Lin, X Ma, LL Wilson… - Nature …, 2024 - nature.com
Genetic interactions mediate the emergence of phenotype from genotype, but technologies
for combinatorial genetic perturbation in mammalian cells are challenging to scale. Here, we …
for combinatorial genetic perturbation in mammalian cells are challenging to scale. Here, we …
Genome-wide CRISPR screens using isogenic cells reveal vulnerabilities conferred by loss of tumor suppressors
Exploiting cancer vulnerabilities is critical for the discovery of anticancer drugs. However,
tumor suppressors cannot be directly targeted because of their loss of function. To uncover …
tumor suppressors cannot be directly targeted because of their loss of function. To uncover …
Regulation of leukemogenesis via redox metabolism
Z Zhang, C Chen, X Li, J Zheng, Y Zhao - Trends in Cell Biology, 2023 - cell.com
Redox metabolism plays a central role in the cellular metabolism network, involves catabolic
and anabolic reactions of diverse biomass, and determines the redox state of cells. It can be …
and anabolic reactions of diverse biomass, and determines the redox state of cells. It can be …
Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity
M Golkowski, A Lius, T Sapre, HT Lau, T Moreno… - Molecular cell, 2023 - cell.com
Dynamic changes in protein-protein interaction (PPI) networks underlie all physiological
cellular functions and drive devastating human diseases. Profiling PPI networks can …
cellular functions and drive devastating human diseases. Profiling PPI networks can …
In silico RNA isoform screening to identify potential cancer driver exons with therapeutic applications
M Anglada-Girotto, L Ciampi, S Bonnal… - Nature …, 2024 - nature.com
Alternative splicing is crucial for cancer progression and can be targeted pharmacologically,
yet identifying driver exons genome-wide remains challenging. We propose identifying such …
yet identifying driver exons genome-wide remains challenging. We propose identifying such …
Chromatin complex dependencies reveal targeting opportunities in leukemia
Chromatin regulators are frequently mutated in human cancer and are attractive drug
targets. They include diverse proteins that share functional domains and assemble into …
targets. They include diverse proteins that share functional domains and assemble into …
PICKLES v3: the updated database of pooled in vitro CRISPR knockout library essentiality screens
LC Novak, J Chou, M Colic, CA Bristow… - Nucleic acids …, 2023 - academic.oup.com
Abstract PICKLES (https://pickles. hart-lab. org) is an updated web interface to a freely
available database of genome-scale CRISPR knockout fitness screens in human cell lines …
available database of genome-scale CRISPR knockout fitness screens in human cell lines …
Dynamic rewiring of biological activity across genotype and lineage revealed by context-dependent functional interactions
Background Coessentiality networks derived from CRISPR screens in cell lines provide a
powerful framework for identifying functional modules in the cell and for inferring the roles of …
powerful framework for identifying functional modules in the cell and for inferring the roles of …
High-throughput CRISPR screening in hematological neoplasms
R Ancos-Pintado, I Bragado-García, ML Morales… - Cancers, 2022 - mdpi.com
Simple Summary High-throughput CRISPR screening provides an unbiased way for
functional genomic studies in hematological malignancies. This approach has been used to …
functional genomic studies in hematological malignancies. This approach has been used to …